ModelEdge
TherapeuticsMD
TXMD
Filing type
10-K
Filing date
Mar 29, 2026
Updated
Mar 30, 2026 ยท 3:43 PM

Filing

10-KFY 2025

Exhibits

EX-3.3COMPOSITE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY, AS AMENDEDEX-3.11CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION, FILED IN THE STATE OF NEVADA, DATED JANUARY 5, 2026EX-21.1SUBSIDIARIES OF THE COMPANYEX-23.1CONSENT OF BERKOWITZ POLLACK BRANTEX-23.2CONSENT OF CARR, RIGGS & INGRAM, L.L.C.EX-31.1CERTIFICATIONEX-31.2CERTIFICATIONEX-32.1CERTIFICATIONEX-32.2CERTIFICATIONGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic